Distribution of hepatitis C virus genotypes among chronic infected injecting drug users in Tehran, Iran

Jundishapur Journal of Microbiology

Volumn 6, Issue 3, 2013, Pages

  Ranjbar Kermani, Fahimeh ^a   Sharifi, Zohreh ^a   Ferdowsian, Fereshteh ^a   Paz, Zahrah ^a   Zamanian, Mahsa ^a  

^a HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

Author keywords

HCV Genotypes; Hepatitis; Injecting Drug Users; Iran; Virus

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DRUG ABUSE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION CONTROL; INJECTING DRUG USER; IRAN; MALE; PATIENT REFERRAL; PREVALENCE; VIRUS IDENTIFICATION; VIRUS TRANSMISSION;

EID: 84877824872     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.5191     Document Type: Article

References (24)

1. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529-38. [DOI] [PubMed]
2. Rosen HR, Martin P. Viral hepatitis in the liver transplant recipient. Infect Dis Clin North Am. 2000;14(3):761-84. [PubMed]
3. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis.2000;20(1):1-16. [PubMed]
4. Cheraghali AM, Abolghasemi H. Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience. Haemophilia. 2009;15(2):487-93. [PubMed]
5. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med.2005;8(2):84-90.
6. Alavian SM, Fallahian F, Lankarani KB. Comparison of Seroepidemiology and Transmission Modes of Viral Hepatitis B in Iran and Pakistan. Hepat Mon. 2007;7(4):233-238.
7. Alizadeh AHM, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan-Iran. World J Gastroenterol. 2005;11(26):4085.
8. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J Gastroenterol.2006;12(43):7025-8. [PubMed]
9. Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM, et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int J Drug Policy. 2007;18(5):359-63. [DOI] [PubMed]
10. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962-73. [DOI] [PubMed]
11. Pawlotsky JM. Treating hepatitis C in "difficult-to-treat" patients. N Engl J Med. 2004;351(5):422-3. [DOI] [PubMed]
12. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev. 2000;13(2):223-35. [PubMed]
13. Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, et al. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol. 2003;69(3):367-75. [DOI] [PubMed]
14. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74 (Pt 11):2391-9. [PubMed]
15. Ahmadi Pour MH, Keivani H, Sabahi F, Alavian SM. Determination of HCV genotypes Iran by PCR-RFLP. Iranian J Publ Health. 2006;35(4):54-61.
16. Amini S, Majd Abadi MM, Alavian SM, Joulaie M, Ahmadipour MH. Distribution of Hepatitis C Virus Genotypes in Iran: A Population-Based Study. Hepat Mon. 2009;9(2):95-102.
17. Sharifi Z, Shooshtari MM, Kermani FR. Identification of HCV genotypes in HCV infected blood donors. Indian J Microbiol. 2010;50(3):275-9. [DOI] [PubMed]
18. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis.2005;5(9):558-67. [DOI] [PubMed]
19. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol. 2004;74(2):246-52. [DOI] [PubMed]
20. Kabir A, Alavian SM, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol. 2006;5:4. [DOI] [PubMed]
21. Ohno O, Mizokami M, Wu RR, Saleh MG, Ohba K, Orito E, et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol. 1997;35(1):201-7. [PubMed]
22. Mahfoud Z, Kassak K, Kreidieh K, Shamra S, Ramia S. Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon. Virol J. 2010;7:96. [DOI] [PubMed]
23. Roman F, Hawotte K, Struck D, Ternes AM, Servais JY, Arendt V, et al. Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World J Gastroenterol. 2008;14(8):1237-43. [PubMed]
24. Morice Y, Cantaloube JF, Beaucourt S, Barbotte L, De Gendt S, Goncales FL, et al. Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol. 2006;78(10):1296-303. [DOI] [PubMed